COG 2013 Blueprint for Neuroblastoma Research
April 14th, 2013 | by: Antonia Palmer
In 2012, the Children’s Oncology Group (COG) Neuroblastoma Committee documented the important current and future research being done to further understand this perplexing disease.
-
Advances in Neuroblastoma Research Conference (ANR 2012) – Invitation to the Parent Symposium and Reception May 8th, 2012 by: Antonia Palmer -
-
NB in the News
-
Changes to the Chemotherapies Used in the COG Stem Cell Transplant Regimen
The chemotherapeutic drugs used during stem-cell transplant for high-risk neuroblastoma appear to be changing under the Children’s Oncology Group (COG) protocol.
-
MYCN Amplification, Possible Therapies, and BET Bromodomain Inhibition
A new post on the NB Globe website provides a detailed look at MYCN amplification in neuroblastoma and the emergence of a new therapy called BET bromodomain inhibition.
Events
-
The Mitchell Fraser Memorial Slo-Pitch Tournament
The Mitchell Fraser Memorial Slo-Pitch Tournament has raised almost $200,000 for neuroblastoma research since 2002.
-
ASCO Annual Meeting 2013
Chicago, USA: The American Society of Clinical Oncology (ASCO) will be hosting their annual meeting.